The American Diabetes Association diabetes research perspective

Diabetes Care

Volumn 35, Issue 6, 2012, Pages 1380-1387

  Fonseca, Vivian A ^a,b   Darsow, Tamara ^b   Kirkman, M Sue ^b   Ratner, Robert E ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMERICAN DIABETES ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC RESEARCH; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; COMMUNITY PROGRAM; DIABETES MELLITUS; EARLY DIAGNOSIS; EXERCISE; FUNDING; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INFORMATION DISSEMINATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MEDICAL EDUCATION; MEDICAL RESEARCH; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT CARE; PERSONALIZED MEDICINE; PREGNANCY DIABETES MELLITUS; PROFESSIONAL DEVELOPMENT; PUBLIC HEALTH; RESEARCH PRIORITY; REVIEW; RISK ASSESSMENT; TRANSLATIONAL RESEARCH; WEIGHT REDUCTION;

BIOMEDICAL RESEARCH; CAREER CHOICE; CONSUMER PARTICIPATION; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EDUCATION, MEDICAL; HUMANS; INFORMATION DISSEMINATION; SOCIETIES, MEDICAL; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 84861773473     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-9001     Document Type: Review

References (30)

1. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011
2. Bell RA, Mayer-Davis EJ, Beyer JW, et al.; SEARCH for Diabetes in Youth Study Group. Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care 2009;32(Suppl. 2):S102-S111
3. Geiss LS, Pan L, Cadwell B, Gregg EW, Benjamin SM, Engelgau MM. Changes in incidence of diabetes in U.S. adults, 1997-2003. Am J Prev Med 2006;30:371-377
4. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010;8:29-41
5. Dall TM, Zhang Y, Chen YJ, Quick WW, Yang WG, Fogli J. The economic burden of diabetes. Health Aff (Millwood) 2010;29:297-303
6. Geiss L, Engelgau M, Pogach L, et al. A national progress report on diabetes: successes and challenges. Diabetes Technol Ther 2005;7:198-203 (Pubitemid 40354588)
7. Vastag B. Increasing R01 competition concerns researchers. J Natl Cancer Inst 2006;98:1436-1438
8. Our commitment to supporting the next generation [article online], 2012. Available from http://nexus.od.nih.gov/all/2012/02/03/our-commitment-to- supporting-the-next-generation/. Accessed 6 April 2012
9. Falagas ME, Ierodiakonou V, Alexiou VG. At what age do biomedical scientists do their best work? FASEB J 2008;22:4067-4070
10. Matthews KR, Calhoun KM, Lo N, Ho V. The aging of biomedical research in the United States. PLoS One 2011;6:e29738
11. Zhao Y, Jiang Z, Zhao T, et al. Reversal of type 1 diabetes via islet b cell regeneration following immune modulation by cord blood-derived multipotent stem cells. BMC Med 2012;10:3
12. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403 (Pubitemid 34437694)
13. Herman WH, Edelstein SL, Ratner RE, et al.; The Diabetes Prevention Program Research Group. The 10-year costeffectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012;35:723-730
14. Roep BO, Atkinson M, von Herrath M. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nat Rev Immunol 2004;4:989-997 (Pubitemid 39620073)
15. Duckworth W, Abraira C, Moritz T, et al.; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-139
16. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572 (Pubitemid 351831357)
17. Gerstein HC, Miller ME, Byington RP, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559 (Pubitemid 351831356)
18. DePalma MT, Rollison J, Camporese M. Psychosocial predictors of diabetes management. Am J Health Behav 2011;35:209-218
19. Nozaki T, Morita C, Matsubayashi S, et al. Relation between psychosocial variables and the glycemic control of patients with type 2 diabetes: a cross-sectional and prospective study. Biopsychosoc Med 2009;3:4
20. Chisholm V, Atkinson L, Donaldson C, Noyes K, Payne A, Kelnar C. Predictors of treatment adherence in young children with type 1 diabetes. J Adv Nurs 2007;57:482-493
21. Akimoto M, Fukunishi I, Kanno K, et al. Psychosocial predictors of relapse among diabetes patients: a 2-year follow-up after inpatient diabetes education. Psychosomatics 2004;45:343-349 (Pubitemid 38823610)
22. Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. Am J Prev Med 2008;35:357-363
23. Pullen-Smith B, Carter-Edwards L, Leathers KH. Community health ambassadors: a model for engaging community leaders to promote better health in North Carolina. J Public Health Manag Pract 2008;14(Suppl.):S73-S81
24. Hemkens LG, Grouven U, Bender R, et al. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 2009;52:1732-1744
25. Jonasson JM, Ljung R, Talbäck M, Haglund B, Gudbjörnsdò ttir S, Steineck G. Insulin glargine use and short-term incidence of malignancies - a population-based follow-up study in Sweden. Diabetologia 2009;52:1745-1754
26. Colhoun HM; SDRN Epidemiology Group. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 2009;52:1755-1765
27. Currie CJ, Poole CD, Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 2009;52:1766-1777
28. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care 2010;33:1674-1685
29. American Diabetes Association. Standards of medical care in diabetes - 2012. Diabetes Care 2012;35(Suppl. 1):S11-S63
30. Bang H, Edwards AM, Bomback AS, et al. Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med 2009;151:775-783